Computer aided drug design – a step closer to selective HDAC-6 inhibitor?

dc.creator	Ružić, Dušan
dc.creator	Nikolić, Katarina
dc.creator	Agbaba, Danica
dc.creator	Ganesan, A.
dc.date.accessioned	2023-09-15T09:39:10Z
dc.date.available	2023-09-15T09:39:10Z
dc.date.issued	2016
dc.identifier.uri	https://farfar.pharmacy.bg.ac.rs/handle/123456789/5028
dc.description.abstract	Histone deacetylases (HDACs) are epigenetic erasers, which are considered as transcriptional repressors and potent anticancer targets. Today, 18 human HDACs are identified and divided in four classes. FDA has approved four Histone Deacetylase Inhibitors (HDACi), defined as pan-HDAC inhibitors...	sr
dc.language.iso	en	sr
dc.publisher	Freiburg Institute for Advanced Studies	sr
dc.relation	info:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172033/RS//	sr
dc.relation	COST CM1406 action	sr
dc.rights	restrictedAccess	sr
dc.source	3rd Freiburg Epigenetic Spring Meeting and COST Action EpiChemBio CM1406, Freiburg, April 10-13	sr
dc.title	Computer aided drug design – a step closer to selective HDAC-6 inhibitor?	sr
dc.type	conferenceObject	sr
dc.rights.license	ARR	sr
dc.description.other	Poster
dc.identifier.rcub	https://hdl.handle.net/21.15107/rcub_farfar_5028
dc.type.version	publishedVersion	sr